How is the field of antibody drug conjugates being reshaped?

Though mRNA technologies are helping to expand the industry's horizons, there manufacture does come with challenges.

How can logistics companies meet the evolving needs of global clients while maintaining resilience over the long-term?

Meet the international coalition working to tackle COVID-19 in low- and middle-income countries.

Applying mRNA technology to the treatment of malaria.

Could mRNA vaccine be the flu interventions of tomorrow?

Defining the best strategies for working with highly potent drug substances.

How a drug approval changed the lives of patients living with rare disease.

We sit down with CureVac's Igor Splawski, who discusses the achievements that could define the next chapter of the mRNA success story.

An institute for the gifted with X in its name, presided over by a wise doctor, has launched two new projects. Somebody call Magneto!